MOLLI Radiology Gallery

The MOLLI® Marker is compatible with ultrasound imaging

Needle insertion

Marker ejection

Needle retraction

Marker successfully deployed

Marker deployment in a chicken breast phantom*

*Nicolae, Alexandru, et al. “Evaluation of a ferromagnetic marker technology for intraoperative localization of nonpalpable breast lesions.” American Journal of Roentgenology 212.4 (2019): 727-733.

Imaging in Patient

Superficial breast ultrasonographic image of the MOLLI Marker alongside a radioactive seed implanted in a patient.**

**Data on file at MOLLI Surgical.

The MOLLI® Marker is compatible with mammographic imaging

Lateral oblique mammographic image of the MOLLI Marker and the radioactive seed implanted in a patient.*

*Dr. Nicole Look Hong, Dr. Frances Wright, Mark Semple, MA Sc; Alexandru Nicolae, MSc; Ananth Ravi, PhD; University of Toronto and Sunnybrook Hospital Odette Cancer Centre. Results of a Phase I, Prospective, Non-randomized Study Evaluating a Magnetic Occult Lesion Instrument (MOLLI) for Excision of Non-palpable Breast Lesions. Poster presented at the 2019 American Society of Breast Surgeons annual meeting, Dallas, Texas. Download the PDF

The MOLLI® Marker is Magnetic Resonance (MR) conditional

The MOLLI Marker is intended to be placed percutaneously in soft tissue to temporarily mark a surgical site intended for surgical removal.

A patient with an implanted MOLLI Marker can be imaged using a 1.5 T or 3.0 T MR system.

Evidence-based use of MRI in breast cancer

Role of MRI in breast cancer management

  • High sensitivity but not so specific.
  • Highly sensitive tool for diagnostic problem-solving.
  • MRI evaluations cost 10x more than screening mammography.

MRI for breast cancer screening, diagnosis, and treatment

  • MRI screening indicated for BRCA mutation or at high risk of breast cancer.
  • Preoperative MR imaging does not improve surgical outcomes.
  • MRI indicated to monitor response during neoadjuvant chemotherapy.

Neoadjuvant therapy workflow using MOLLI